Literature DB >> 20335533

Suppression of host innate immune response by Burkholderia pseudomallei through the virulence factor TssM.

Kai Soo Tan1, Yahua Chen, Yaw-Chyn Lim, Gek-Yen Gladys Tan, Yichun Liu, Yan-Ting Lim, Paul Macary, Yunn-Hwen Gan.   

Abstract

Burkholderia pseudomallei is a Gram-negative saprophyte that is the causative agent of melioidosis, a severe infectious disease endemic in Northern Australia and Southeast Asia. This organism has sparked much scientific interest in the West because of its classification as a potential bioterrorism agent by the U.S. Centers for Disease Control and Prevention. However, relatively little is known about its pathogenesis. We demonstrate that B. pseudomallei actively inhibits NF-kappaB and type I IFN pathway activation, thereby downregulating host inflammatory responses. We found the virulence factor TssM to be responsible for this activity. TssM interferes with the ubiquitination of critical signaling intermediates, including TNFR-associated factor-3, TNFR-associated factor-6, and IkappaBalpha. The expression but not secretion of TssM is regulated by the type III secretion system. We demonstrate that TssM is important for B. pseudomallei infection in vivo as inflammation in the tssM mutant-infected mice is more severe and corresponds to a more rapid death compared with wild-type bacteria-infected mice. Abs to TssM can be detected in the sera of melioidosis patients, indicating that TssM is functionally expressed in vivo and thus could contribute to bacterial pathogenesis in human melioidosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20335533     DOI: 10.4049/jimmunol.0902663

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  Identification of the major ubiquitin-binding domain of the Pseudomonas aeruginosa ExoU A2 phospholipase.

Authors:  David M Anderson; Jimmy B Feix; Andrew L Monroe; Francis C Peterson; Brian F Volkman; Arthur L Haas; Dara W Frank
Journal:  J Biol Chem       Date:  2013-08-01       Impact factor: 5.157

2.  Burkholderia pseudomallei suppresses Caenorhabditis elegans immunity by specific degradation of a GATA transcription factor.

Authors:  Song-Hua Lee; Rui-Rui Wong; Chui-Yoke Chin; Tian-Yeh Lim; Su-Anne Eng; Cin Kong; Nur Afifah Ijap; Ming-Seong Lau; Mei-Perng Lim; Yunn-Hwen Gan; Fang-Lian He; Man-Wah Tan; Sheila Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-26       Impact factor: 11.205

3.  Recent Advances in Burkholderia mallei and B. pseudomallei Research.

Authors:  Christopher L Hatcher; Laura A Muruato; Alfredo G Torres
Journal:  Curr Trop Med Rep       Date:  2015-06

4.  Regulation of type VI secretion system during Burkholderia pseudomallei infection.

Authors:  Yahua Chen; Jocelyn Wong; Guang Wen Sun; Yichun Liu; Gek-Yen Gladys Tan; Yunn-Hwen Gan
Journal:  Infect Immun       Date:  2011-06-13       Impact factor: 3.441

Review 5.  Autophagy and burkholderia.

Authors:  Rodney J Devenish; Shu-chin Lai
Journal:  Immunol Cell Biol       Date:  2014-10-21       Impact factor: 5.126

Review 6.  Expanding Role of Type II Secretion in Bacterial Pathogenesis and Beyond.

Authors:  Nicholas P Cianciotto; Richard C White
Journal:  Infect Immun       Date:  2017-04-21       Impact factor: 3.441

7.  Burkholderia cenocepacia J2315 escapes to the cytosol and actively subverts autophagy in human macrophages.

Authors:  Souhaila Al-Khodor; Kimberly Marshall-Batty; Vinod Nair; Li Ding; David E Greenberg; Iain D C Fraser
Journal:  Cell Microbiol       Date:  2013-11-06       Impact factor: 3.715

Review 8.  Exploitation of the host ubiquitin system by human bacterial pathogens.

Authors:  Hiroshi Ashida; Minsoo Kim; Chihiro Sasakawa
Journal:  Nat Rev Microbiol       Date:  2014-05-07       Impact factor: 60.633

Review 9.  Melioidosis: molecular aspects of pathogenesis.

Authors:  Joshua K Stone; David DeShazer; Paul J Brett; Mary N Burtnick
Journal:  Expert Rev Anti Infect Ther       Date:  2014-10-14       Impact factor: 5.091

Review 10.  Deubiquitinating enzymes as promising drug targets for infectious diseases.

Authors:  Bindu Nanduri; Akamol E Suvarnapunya; Malabi Venkatesan; Mariola J Edelmann
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.